A novel human 3D lung microtissue model for nanoparticle-induced cell-matrix alterations

Abstract

Background Multi-walled carbon nanotubes (MWCNT) have been shown to elicit the release of inflammatory and pro-fibrotic mediators, as well as histopathological changes in lungs of exposed animals. Current standards for testing MWCNTs and other nanoparticles (NPs) rely on low-throughput in vivo studies to assess acute and chronic toxicity and potential hazard to humans. Several alternative testing approaches utilizing two-dimensional (2D) in vitro assays to screen engineered NPs have reported conflicting results between in vitro and in vivo assays. Compared to conventional 2D in vitro or in vivo animal model systems, three-dimensional (3D) in vitro platforms have been shown to more closely recapitulate human physiology, providing a relevant, more efficient strategy for evaluating acute toxicity and chronic outcomes in a tiered nanomaterial toxicity testing paradigm. Results As inhalation is an important route of nanomaterial exposure, human lung fibroblasts and epithelial cells were co-cultured with macrophages to form scaffold-free 3D lung microtissues. Microtissues were exposed to multi-walled carbon nanotubes, M120 carbon black nanoparticles or crocidolite asbestos fibers for 4 or 7 days, then collected for characterization of microtissue viability, tissue morphology, and expression of genes and selected proteins associated with inflammation and extracellular matrix remodeling. Our data demonstrate the utility of 3D microtissues in predicting chronic pulmonary endpoints following exposure to MWCNTs or asbestos fibers. These test nanomaterials were incorporated into 3D human lung microtissues as visualized using light microscopy. Differential expression of genes involved in acute inflammation and extracellular matrix remodeling was detected using PCR arrays and confirmed using qRT-PCR analysis and Luminex assays of selected genes and proteins. Conclusion 3D lung microtissues provide an alternative testing platform for assessing nanomaterial-induced cell-matrix alterations and delineation of toxicity pathways, moving towards a more predictive and physiologically relevant approach for in vitro NP toxicity testing. Electronic supplementary material The online version of this article (10.1186/s12989-019-0298-0) contains supplementary material, which is available to authorized users.

A Clearance Period After Soluble Lead Nanoparticle Inhalation did not Ameliorate the Negative Effects on Target Tissues Due to Decreased Immune Response

“…TNFα and IL-6 are major proinflammatory cytokines, while the IL-1 family includes 11 members expressed by numerous cell types, which comprises both proinflammatory and antiinflammatory responses [61]. Previously, the exposure to NPs was found to deregulate many cytokines, including several IL family members or TNFα [62]. Interestingly, the same types of metal NPs can exhibit opposite effects on immune system [63].…”

A Human-Relevant 3D In Vitro Platform for an Effective and Rapid Simulation of Workplace Exposure to Nanoparticles: Silica Nanoparticles as Case Study

“…In this complex scenario, the development of three-dimensional (3D) in vitro models coupled with a nebulizer system (as explained above) that can mimic tissue structure and in vivo functionalities could provide great benefits to answer, although partially, the above questions raised by in vivo and epidemiological studies, especially regarding toxicity testing [ 17 , 18 ]. Advanced in vitro 3D models resembling the lung are currently available, as two-dimensional (2D) models lack the complexity of physiological systems and long-term exposure studies [ 18 , 19 ]. Pulmonary interface is mimicked by using a 3D (airway/lung) model culture at the air–liquid interface (ALI), which more closely resembles the in vivo lung epithelium, where the apical surface is exposed to air and the basal surface of the cells is in contact with the liquid culture medium.…”

3d Bioprinted Material That Recapitulates the Perivascular Bone Marrow Structure for Sustained Hematopoietic and Cancer Models

“…3D bioprinting has revolutionized the manner to create 3D in vitro culture systems, allowing for rapid fabrication of constructs with pre-defined geometries. However, despite its success in creating a wide array of tissues in silico (e.g., breast, brain, lung, bladder), faithfully replicating very soft tissues through 3D bioprinting has proven difficult due to their limited printability and low fidelity [67][68][69][70][71][72][73][74][75][76][77]. This is a significant obstacle because the degree of control over the composition, size, and structure of 3D bioprinted scaffolds can meaningfully influence physiological and pathological models, including screening for drug performance.…”